BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12084606)

  • 21. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
    Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
    Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
    Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
    Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel deletions in MYH7 and MYBPC3 identified in Indian families with familial hypertrophic cardiomyopathy.
    Waldmüller S; Sakthivel S; Saadi AV; Selignow C; Rakesh PG; Golubenko M; Joseph PK; Padmakumar R; Richard P; Schwartz K; Tharakan JM; Rajamanickam C; Vosberg HP
    J Mol Cell Cardiol; 2003 Jun; 35(6):623-36. PubMed ID: 12788380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation of Arg723Gly in beta-myosin heavy chain gene in five Chinese families with hypertrophic cardiomyopathy.
    Yang JH; Zheng DD; Dong NZ; Yang XJ; Song JP; Jiang TB; Cheng XJ; Li HX; Zhou BY; Zhao CM; Jiang WP
    Chin Med J (Engl); 2006 Nov; 119(21):1785-9. PubMed ID: 17097032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].
    Ramírez CD; Padrón R
    Invest Clin; 2004 Mar; 45(1):69-99. PubMed ID: 15058760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.
    Ntusi NA; Shaboodien G; Badri M; Gumedze F; Mayosi BM
    Cardiovasc J Afr; 2016; 27(3):152-158. PubMed ID: 27841901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of MYH7 gene mutation sites in hypertrophic cardiomyopathy and its significance.
    Liu HT; Ji FF; Wei L; Zuo AJ; Gao YX; Qi L; Jin B; Wang JG; Zhao P
    Chin Med J (Engl); 2019 Dec; 132(23):2835-2841. PubMed ID: 31856055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
    Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
    Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mutation and clinical relevance in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy].
    Jie L; Wenling L; Dayi H; Tiangang Z; Wen L; Zhanfeng M; Jie Y; Wenli X; Cuilan L; Lei L; Guozhong P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):682-9. PubMed ID: 26955724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Screening and analysis of the mutations on beta-myosin heavy chain gene in 3 Chinese families with hypertrophic cardiomyopathy].
    Feng XL; Fan XP; Yang ZW; Yang FH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):110-3. PubMed ID: 21426742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequencing identifies a novel MYH7 p.G407C mutation responsible for familial hypertrophic cardiomyopathy.
    Guo Q; Xu Y; Wang X; Guo Y; Xu R; Sun K; Chen S
    DNA Cell Biol; 2014 Oct; 33(10):699-704. PubMed ID: 24963656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children.
    Greber-Platzer S; Marx M; Fleischmann C; Suppan C; Dobner M; Wimmer M
    J Mol Cell Cardiol; 2001 Jan; 33(1):141-8. PubMed ID: 11133230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].
    Laredo R; Monserrat L; Hermida-Prieto M; Fernández X; Rodríguez I; Cazón L; Alvariño I; Dumont C; Piñón P; Peteiro J; Bouzas B; Castro-Beiras A
    Rev Esp Cardiol; 2006 Oct; 59(10):1008-18. PubMed ID: 17125710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.
    Heradien M; Revera M; van der Merwe L; Goosen A; Corfield VA; Brink PA; Mayosi BM; Moolman-Smook JC
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S18-24. PubMed ID: 19880069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
    Fananapazir L; Dalakas MC; Cyran F; Cohn G; Epstein ND
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3993-7. PubMed ID: 8483915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
    Girolami F; Ho CY; Semsarian C; Baldi M; Will ML; Baldini K; Torricelli F; Yeates L; Cecchi F; Ackerman MJ; Olivotto I
    J Am Coll Cardiol; 2010 Apr; 55(14):1444-53. PubMed ID: 20359594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.